Asymptotically Unbiased Synthetic Control Methods by Distribution Matching

• URL: http://arxiv.org/abs/2307.11127v3
• Date: Wed, 15 May 2024 04:05:37 GMT
• Title: Asymptotically Unbiased Synthetic Control Methods by Distribution Matching
• Authors: Masahiro Kato, Akari Ohda, Masaaki Imaizumi,
• Abstract summary: Existing Synthetic Control Methods (SCMs) suffer from an endogeneity problem, the correlation between the outcomes of untreated units and the error term of the synthetic control, which yields a bias in the treatment effect estimator. We propose a novel SCM based on density matching, assuming that the density of outcomes of the treated unit can be approximated by a weighted average of the joint density of untreated units.
• Score: 14.030354616779325
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Synthetic Control Methods (SCMs) have become an essential tool for comparative case studies. The fundamental idea of SCMs is to estimate the counterfactual outcomes of a treated unit using a weighted sum of the observed outcomes of untreated units. The accuracy of the synthetic control (SC) is critical for evaluating the treatment effect of a policy intervention; therefore, the estimation of SC weights has been the focus of extensive research. In this study, we first point out that existing SCMs suffer from an endogeneity problem, the correlation between the outcomes of untreated units and the error term of the synthetic control, which yields a bias in the treatment effect estimator. We then propose a novel SCM based on density matching, assuming that the density of outcomes of the treated unit can be approximated by a weighted average of the joint density of untreated units (i.e., a mixture model). Based on this assumption, we estimate SC weights by matching the moments of treated outcomes with the weighted sum of moments of untreated outcomes. Our proposed method has three advantages over existing methods: first, our estimator is asymptotically unbiased under the assumption of the mixture model; second, due to the asymptotic unbiasedness, we can reduce the mean squared error in counterfactual predictions; third, our method generates full densities of the treatment effect, not merely expected values, which broadens the applicability of SCMs. We provide experimental results to demonstrate the effectiveness of our proposed method.

Related papers

• Identification of Average Causal Effects in Confounded Additive Noise Models [7.064432289838905]
  We introduce a novel approach for estimating the average causal effects (ACEs) of any subset of the treatment variables on the outcome. We also propose a randomized algorithm that further reduces the number of required interventions to poly-logarithmic in the number of nodes. This establishes that a poly-logarithmic number of interventions is sufficient to infer the causal effects of any subset of treatments on the outcome in confounded ANMs with high probability.
  arXiv  Detail & Related papers  (2024-07-13T21:46:57Z)
• Uncertainty Quantification in Heterogeneous Treatment Effect Estimation with Gaussian-Process-Based Partially Linear Model [2.1212179660694104]
  Estimating heterogeneous treatment effects across individuals has attracted growing attention as a statistical tool for performing critical decision-making. We propose a Bayesian inference framework that quantifies the uncertainty in treatment effect estimation to support decision-making in a relatively small sample size setting.
  arXiv  Detail & Related papers  (2023-12-16T12:42:28Z)
• Optimal Transport for Treatment Effect Estimation [42.50410909962438]
  Estimating conditional average treatment effect from observational data is highly challenging due to the existence of treatment selection bias. Prevalent methods mitigate this issue by aligning distributions of different treatment groups in the latent space. We propose a principled approach named Entire Space CounterFactual Regression (ESCFR), which is a new take on optimal transport in the context of causality.
  arXiv  Detail & Related papers  (2023-10-27T17:22:45Z)
• Covariate-Balancing-Aware Interpretable Deep Learning models for Treatment Effect Estimation [15.465045049754336]
  We propose an upper bound for the bias of average treatment estimation under the strong ignorability assumption. We implement this upper bound as an objective function being minimized by leveraging a novel additive neural network architecture. The proposed method is illustrated by re-examining the benchmark datasets for causal inference, and it outperforms the state-of-art.
  arXiv  Detail & Related papers  (2022-03-07T07:42:40Z)
• Treatment Effect Risk: Bounds and Inference [58.442274475425144]
  Since the average treatment effect measures the change in social welfare, even if positive, there is a risk of negative effect on, say, some 10% of the population. In this paper we consider how to nonetheless assess this important risk measure, formalized as the conditional value at risk (CVaR) of the ITE distribution. Some bounds can also be interpreted as summarizing a complex CATE function into a single metric and are of interest independently of being a bound.
  arXiv  Detail & Related papers  (2022-01-15T17:21:26Z)
• Assessment of Treatment Effect Estimators for Heavy-Tailed Data [70.72363097550483]
  A central obstacle in the objective assessment of treatment effect (TE) estimators in randomized control trials (RCTs) is the lack of ground truth (or validation set) to test their performance. We provide a novel cross-validation-like methodology to address this challenge. We evaluate our methodology across 709 RCTs implemented in the Amazon supply chain.
  arXiv  Detail & Related papers  (2021-12-14T17:53:01Z)
• Weighting-Based Treatment Effect Estimation via Distribution Learning [14.438302755258547]
  We develop a distribution learning-based weighting method for treatment effect estimation. Our method outperforms several cutting-edge weighting-only benchmarking methods. It maintains its advantage under a doubly-robust estimation framework.
  arXiv  Detail & Related papers  (2020-12-26T20:15:44Z)
• Bayesian prognostic covariate adjustment [59.75318183140857]
  Historical data about disease outcomes can be integrated into the analysis of clinical trials in many ways. We build on existing literature that uses prognostic scores from a predictive model to increase the efficiency of treatment effect estimates.
  arXiv  Detail & Related papers  (2020-12-24T05:19:03Z)
• Increasing the efficiency of randomized trial estimates via linear adjustment for a prognostic score [59.75318183140857]
  Estimating causal effects from randomized experiments is central to clinical research. Most methods for historical borrowing achieve reductions in variance by sacrificing strict type-I error rate control.
  arXiv  Detail & Related papers  (2020-12-17T21:10:10Z)
• Enabling Counterfactual Survival Analysis with Balanced Representations [64.17342727357618]
  Survival data are frequently encountered across diverse medical applications, i.e., drug development, risk profiling, and clinical trials. We propose a theoretically grounded unified framework for counterfactual inference applicable to survival outcomes.
  arXiv  Detail & Related papers  (2020-06-14T01:15:00Z)
• Learning Decomposed Representation for Counterfactual Inference [53.36586760485262]
  The fundamental problem in treatment effect estimation from observational data is confounder identification and balancing. Most of the previous methods realized confounder balancing by treating all observed pre-treatment variables as confounders, ignoring further identifying confounders and non-confounders. We propose a synergistic learning framework to 1) identify confounders by learning representations of both confounders and non-confounders, 2) balance confounder with sample re-weighting technique, and simultaneously 3) estimate the treatment effect in observational studies via counterfactual inference.
  arXiv  Detail & Related papers  (2020-06-12T09:50:42Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.